RecruitingNot ApplicableNCT05692882

A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China

To Evaluate the Safety and Efficacy of the NOVA Intracranial Drug-eluting Stent System in "real World" Patients with Intracranial Atherosclerotic Stenosis: a Prospective, Multicenter, Post-marketing Registry Clinical Study (NOVA II)

Sponsor

Sino Medical Sciences Technology Inc.

Enrollment

1,000 participants

Start Date

Nov 16, 2023

Study Type

INTERVENTIONAL

Conditions

Intracranial Arteriosclerosis Stenosis Artery Drug-Eluting Stents Intracranial Artery Stenosis

Summary

The primary objective of this trial is to evaluate the long-term safety and efficacy of the NOVA intracranial drug-eluting stent system in "real world" patients with intracranial atherosclerotic stenosis.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Drug-Eluting Stents for people with drug-eluting stents, intracranial arteriosclerosis, and other related conditions. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDrug-Eluting Stents

The NOVA stent is a sirolimus-eluting stent system designed for intracranial artery stenosis with a rapid exchangeable balloon

Locations(5)

First People's Hospital of Chenzhou

Chenzhou, China

Ganzhou People's Hospital

Ganzhou, China

Jinhua Municipal Central Hospital

Jinhua, China

The First Affiliated Hospital of Ningbo University

Ningbo, China

Shanxi Cardiovascular Hospital

Shanxi, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05692882

Related Trials

PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

NCT0690274019 locations

Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome

NCT053974052 locations

The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis

NCT0675776424 locations

Gut Microbiota and Prognostic Outcomes in Intracranial Arterial Stenosis Patients（GROW-ICAS）

NCT070852991 location